Literature DB >> 19426393

Clinical study of the relationship between inflammatory bowel diseases and colorectal neoplasms.

Yu Jie Zhao1, Yao Zong Yuan.   

Abstract

OBJECTIVE: To investigate the incidence of colorectal cancer in inflammatory bowel disease (IBD) patients and its risk factors.
METHODS: Data on 513 patients in the last 10 years from Ruijin Hospital were collected. Their medical histories were put in database and analyzed including their socio-demographic features, pathogenetic conditions, diagnostic methods, possible related risk factors, treatment and outcome.
RESULTS: Among the 513 were 242 with ulcerative colitis (UC), among whom four patients developed cancers and four had precancerous lesions. None of the 271 CD patients developed cancer. The incidence of both cancer and precancerosis in the UC patients was 1.65%. Through multifactorial logistic regression analysis, loss of weight, other disease complications and frequent relapses were proved to be the most probable risk factors.
CONCLUSION: The incidence of IBD has kept on rising in recent years. Clinically, UC patients have more probability of developing colorectal cancer than CD patients. The main risk factors of developing colorectal cancer in UC patients are frequent relapses, weight loss and other complications.

Entities:  

Mesh:

Year:  2009        PMID: 19426393     DOI: 10.1111/j.1751-2980.2009.00372.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  3 in total

1.  Inflammation and colorectal cancer: does aspirin affect the interaction between cancer and immune cells?

Authors:  Michael Bergman; Meir Djaldetti; Hertzel Salman; Hanna Bessler
Journal:  Inflammation       Date:  2011-02       Impact factor: 4.092

Review 2.  Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Sawan Bopanna; Ashwin N Ananthakrishnan; Saurabh Kedia; Vijay Yajnik; Vineet Ahuja
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-02-21

3.  A network pharmacology approach to establish the pharmacological mechanism of JiaWeiXianJiTang on inflammatory bowel disease.

Authors:  Ling-Jia Tao; Wen-Ting Chen; Lin Jing; Qing Ji; Jian-Lin Ren
Journal:  Biomed Rep       Date:  2017-02-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.